A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors

Brian Golbourn(University of Pittsburgh), James T. Rutka(University of Toronto)
Neuro-Oncology
July 9, 2024
Cited by 5


Related Papers

No related papers found

Powered by citation graph analysis